Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease

• Quan Yuan ,

  Contributed equally to this work with: Quan Yuan, Liu-Wei Song

  Affiliation State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China

  ⨯
• Liu-Wei Song ,

  Contributed equally to this work with: Quan Yuan, Liu-Wei Song

  Affiliation State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China

  ⨯
• Daniela Cavallone,

  Affiliation Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses, Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Pisa, Italy

  ⨯
• Francesco Moriconi,

  Affiliation Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses, Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Pisa, Italy

  ⨯
• Beatrice Cherubini,

  Affiliation Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses, Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Pisa, Italy

  ⨯
• Piero Colombatto,

  Affiliation Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses, Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Pisa, Italy

  ⨯
• Filippo Oliveri,

  Affiliation Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses, Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Pisa, Italy

  ⨯
• Barbara Agata Coco,

  Affiliation Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses, Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Pisa, Italy

  ⨯
• Gabriele Ricco,

  Affiliation Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses, Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Pisa, Italy

  ⨯
• Ferruccio Bonino,

  Affiliation Digestive and Liver Disease, General Medicine II Unit, University Hospital of Pisa, Pisa, Italy

  ⨯
• James Wai Kuo Shih,

  Affiliation State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China

  ⨯
• Ning-Shao Xia ,

  ¶‡ These authors also contributed equally to this work.

  Affiliation State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China

  ⨯
• Maurizia Rossana Brunetto

  * E-mail: brunettomaurizia@gmail.com

  ¶‡ These authors also contributed equally to this work.

  Affiliation Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses, Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Pisa, Italy

  ⨯